Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

John S. Adams, M.D.
John S. Adams, M.D.

Specialty:

Endocrinology
Diabetes
Metabolism
Internal Medicine
Orthopaedic Surgery

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Professor and Vice Chair for Research, Department of Orthopaedic Surgery
Professor of Medicine, Department of Molecular, Cell and Developmental Biology
Director, UCLA/Orthopaedic Hospital Research Center
Member, JCCC Community

Education:

Fellowship:
Endocrinology Diabetes and Metabolism, Massachusetts General Hospital, 1979 - 1982
Endocrinology Diabetes and Metabolism, University of Kansas Medical Center, 1978 - 1979
Residency:
Internal Medicine, University of Kansas Medical Center, 1975 - 1978
Internship:
Internal Medicine, University of Kansas Medical Center, 1974 - 1975
Medical Degree:
M.D., University of Kansas Medical Center, 1974

Certification(s):

Medical Board Certification(s):
Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine, 1985
Internal Medicine, American Board of Internal Medicine, 1978

Contact Information:

Phone:
(310) 267-5585 Office
(310) 319-1234 Clinic
(310) 825-1394 Admin
Email:

Practice Information:

Clinical Interest(s):
Vitamin D
Osteoporosis

Scientific Interest(s):

Dr. John Adams is Director of the Orthopaedic Hospital Research Center, where he is charged with building an interschool (the College and School of Medicine), multidisciplinary program of research in musculoskeletal sciences. His bench-to-bedside (translational) and clinical research efforts are targeted at understanding
  1. the concerted role of heterogeneous nuclear ribonucleoproteins and heat shock proteins in hormone-directed chromatin remodeling, transcription, transcript splicing and miRNA regulation of mRNA handling,
  2. the role of vitamin D in the human innate and adaptive immune response, and
  3. the contribution of human vitamin D insufficiency to states of immuno-insufficiency and abnormal skeletal and energy homeostasis.

Selected Cancer-Related Publications:

Hokugo A, Christensen R, Chung EM, Sung EC, Felsenfeld AL, Sayre JW, Garrett N, Adams JS, Nishimura I. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. J Bone Miner Res. 2010 Jun;25(6):1337-49.

Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT. Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res. 2007 Jun;22(6):931-7.

Evans KN, Taylor H, Zehnder D, Kilby MD, Bulmer JN, Shah F, Adams JS, Hewison M. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy. Am J Pathol. 2004 Sep;165(3):807-13.

Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res. 2003 Mar;18(3):579-82.

Adams JS, Fernandez M, Gacad MA, Gill PS, Endres DB, Rasheed S, Singer FR. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood. 1989 Jan;73(1):235-9.